Latest Fiji News

Alice Queen Limited has bolstered its Horn Island gold project with an updated resource of 569,000 ounces and a robust Project Definition Study showing a pre-tax NPV of A$706 million. A 2026 drilling program is underway to test a large-scale Exploration Target of up to 2.3 million ounces.

The Calmer Co. has locked in an exclusive global distribution agreement for its kava extract ingredients, underpinning a potential A$25 million revenue stream over three years across key markets including the US and ASEAN.

The Calmer Co. has pushed back the closing date of its $3.5 million renounceable entitlement offer to give shareholders more time to participate, including those overseas.

Dome Gold Mines (ASX:DME) is raising up to AUD 2 million through unsecured convertible notes to accelerate its Sigatoka feasibility study, mining lease application, and copper-gold exploration amid rising metal prices.

The Calmer Co. has secured a long-term supply agreement for premium noble kava from Papua New Guinea and Vanuatu, underpinning its manufacturing growth and diversified Pacific sourcing network.

T&G Global has agreed to sell its T&G Fresh business in three transactions worth a combined enterprise value of NZD 72.65 million, aiming to sharpen its focus on premium apples and VentureFruit platforms while reducing debt.

The Calmer Co. has signed a binding heads of agreement with Kaiming Agro Processing to establish a long-term manufacturing partnership, leveraging advanced extraction technology in Fiji to scale its premium botanical ingredients business globally.

Streamplay Studio Limited has reported its fifth straight quarter of positive operating cash flow, driven by strong customer receipts and strategic publishing deals. The company is advancing multiple game releases and expanding its cloud gaming footprint across new regions.

The Calmer Co International Ltd is raising up to $3.5 million through a 1-for-1 renounceable entitlement offer priced at $0.001 per share, including free attaching options exercisable at $0.002. The capital will fund debt repayment, inventory expansion, marketing, and product launches.

Firebrick Pharma expanded its patent portfolio with grants in Canada and New Zealand while achieving 43% sales growth in FY26 despite steady operating expenses. The company is advancing Nasodine's commercial rollout across Southeast Asia and the US.

DXN Limited has landed a $1 million contract to deliver a Cable Landing Station in American Samoa, reinforcing its foothold in Pacific telecom infrastructure while divesting a non-core Tasmanian data centre.

The Calmer Co. has won Coles' approval for its innovative Fiji Kava® FZZR™ product, extending its Australian supermarket reach while gearing up for a broader U.S. retail rollout supported by a key brokerage partnership.